Abingdon Health (LON:ABDX) Posts Quarterly Earnings Results

Abingdon Health (LON:ABDXGet Free Report) posted its quarterly earnings data on Tuesday. The company reported GBX (0.71) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 62.56% and a negative net margin of 20.72%.

Abingdon Health Trading Down 10.7%

LON ABDX opened at GBX 7.51 on Tuesday. The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64. The stock’s 50-day simple moving average is GBX 6.11 and its two-hundred day simple moving average is GBX 6.27. Abingdon Health has a twelve month low of GBX 5.10 and a twelve month high of GBX 9. The company has a market capitalization of £18.62 million, a price-to-earnings ratio of -10.28 and a beta of 0.13.

About Abingdon Health

(Get Free Report)

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.

Further Reading

Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.